|
O.A. Polyakova, Yu.M. Tkachenko, O.D. Ostroumova
Relationship between non-alcoholic fatty liver disease and cardiovascular disease: focus on the use of ursodeoxycholic acid
|
№1-2 / 2023
|
|
O.A. Polyakova, L.D. Kozgunova, O.D. Ostroumova
Metabolically associated fatty liver disease: the role of ademetionine
|
№1-2 / 2023
|
|
S.A. Bulgakov
ESSENTIAL PHOSPHOLIPIDS IN THE TREATMENT OF HEPATIC DISORDERS
|
№s3 / 2018
|
|
E.V. Balukova (1), N.V. Baryshnikova (1), L.N. Belousova (2)
NONALCOHOLIC FATTY LIVER DISEASE: CURRENT STATE OF PROBLEM
|
№2 / 2016
|
|
O.M. Antonenko
CORRECT WEIGHT LOSS: SUPPORT THE LIVER FUNCTION
|
№2 / 2014
|
|
R. S. Oskanova, L.Yu.Ilchenko, I.G.Fedorov
CHRONIC HEPATIC DISEASES: FROM PATHOGENESIS TO TREATMENT
|
№14 / 2013
|
|
S. M. Alekhin, M. N. Somova
NONALCOHOLIC FATTY LIVER DISEASE: NEW POTENTIALS FOR THE COMBINED THERAPY
|
№10 / 2013
|
|
E.P. Yakovenko 1, A.V. Yakovenko 1, A.V. Kagramanova 1, A.S. Pryanishnikova 1, A.N. Ivanov 1, N.A. Agafonova 1, T.V. Volosheynikova 2, Yu.V. Grigoryeva 2
Modern Approaches To The Therapy Of Cirrhotic Patients
|
№13 / 2012
|
|
A.V. Kalinin
Alcohol Abuse And Alcoholic Liver Disease
|
№13 / 2012
|
|
V.A. Molochkov 1,2, E.S. Yakubovskaya 1
For Use Of Heptral In Generalized Psoriasis
|
№10 / 2012
|
|
L.A. Zvenigorodskaya, E.A. Cherkashova, N.G. Samsonova
Hepatoprotectors In The Treatment Of Nonalcoholic Fatty Liver Disease
|
№15 / 2011
|
|
A.N. Kazyulin, L.Z. Vel’cher, I.A. Koroleva
Hepatotoxicity During Anticancer Chemotherapy Of Oncological Diseases And Methods Of Its Correction
|
№17 / 2010
|
Русский
